Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I1DZ
|
||||
Former ID |
DIB008557
|
||||
Drug Name |
DE-110
|
||||
Synonyms |
Selective glucocorticoid receptor agonist (allergy), Santen
|
||||
Indication | Xerophthalmia [ICD10:E50.6-E50.7] | Phase 2 | [523248] | ||
Company |
Santen Pharmaceutical Co Ltd
|
||||
Target and Pathway | |||||
Target(s) | Glucocorticoid receptor | Target Info | Agonist | [549039] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.